Stamford, CT -- (SBWIRE) -- 01/18/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Intercept Pharmaceuticals Inc (NASDAQ:ICPT), VeriFone Systems Inc (NYSE:PAY), Seattle Genetics, Inc. (NASDAQ:SGEN), Vantiv Inc (NYSE:VNTV)
Intercept Pharmaceuticals Inc (NASDAQ:ICPT) opened the session at $267.35, trading in a range of $267.02 - $320.00. The stock showed a positive performance of +5.50% in the last trading session from its previous close of $277.62 and closed at $292.89. The stock traded on a volume of 1.73 million shares and the average volume of the stock remained 1.04 million shares. Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver diseases utilizing its bile acid chemistry.
For How Long ICPT will Fight for Profitability? Read This Trend Analysis report
VeriFone Systems Inc (NYSE:PAY) traded 1.70 million shares in the last business day while the average volume of the stock remained 2.23 million shares. The stock showed a negative movement of -0.96% to end at $28.968. The 52 week range of the stock remained $15.34 - $36.13. VeriFone Systems, Inc. (VeriFone), formerly VeriFone Holdings, Inc., is a holding company for VeriFone, Inc. The Company is engaged in the secure electronic payment solutions. It provides solutions, and services for the financial, retail, hospitality, petroleum, transportation, government, and healthcare vertical markets.
Has PAY Found The Bottom And Ready To Gain Momentum? Find Out Here
Seattle Genetics, Inc. (NASDAQ:SGEN) reported 1.70 million shares were exchanged during the last trade, while the average volume is about 875,321 shares. The stock escalated +3.30% and finished the day at $47.95. The beta of the stock is recorded at 1.18. Seattle Genetics, Inc. is biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer. Its product candidate, ADCETRIS or brentuximab vedotin is approved by United States Food and Drug Administration (FDA) in two indications: the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT).
For How Long SGEN’s Gloss will Attract Investors? Find out via this report
Vantiv Inc (NYSE:VNTV) shares dropped -1.24 percent from its previous close of $33.01 to close at $1.55. Traded with volume of 1.70 million shares in the prior session and the average volume of the stock remained 1.49 million shares. Vantiv, Inc., formerly Advent-Kong Blocker Corp. is a holding company that conducts its operations through its majority-owned subsidiaries, Vantiv Holding, LLC (Vantiv Holding) and Transactive Ecommerce Solutions Inc. (Transactive). The Company held 50.9% interest in the subsidiaries. The Company operates in two segments: Merchant Services and Financial Institution Services.
Will VNTV Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)